Oncology/Hematology
Hematology
More in Hematology
May become "treatment of choice" over brentuximab vedotin for all disease stages
Likelihood of severe maternal morbidity more than 20 times higher versus the general population
News, features, and commentary about cancer-related issues
10% of patients in trials leading to eli-cel's approval developed MDS or AML
News, features, and commentary about cancer-related issues
News, features, and commentary about cancer-related issues
Benefits of voxelotor (Oxbryta) no longer outweigh the risks, Pfizer says
Fidanacogene elaparvovec reduces bleeding episodes by 71% after a single infusion
News, features, and commentary about cancer-related issues
Regimen tops best historical response rate with chemoimmunotherapy in this setting
News, features, and commentary about cancer-related issues
Incidence almost identical to that with standard cancer treatment in randomized trials
For patients with vaso-occlusive episodes, lactated Ringer was better than normal saline
Patient achieves remission with biologic agent currently used for myeloma
